Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The Rotterdam Study aims to understand various diseases in older adults.

Androgens can both increase and decrease hair growth in different parts of the body.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Finasteride improves hair loss in women with hyperandrogenism.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Genetics and hormones cause hair loss; finasteride treats it safely.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Hormonal therapies are safe and effective for treating adult women's acne.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.